Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
5.974,07
0,73%
NASDAQ
19.764,89
0,98%
Bitcoin
93.950,01
-0,78%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Cotinga Pharmaceuticals Inc (COT) Cotinga Pharmaceuticals Inc (COT) Notizie

COT

Cotinga Pharmaceuticals (COT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:COT
DataOraFonteTitoloSimboloCompagnia
15/10/202014:01PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - COTTSXV:COTCotinga Pharmaceuticals Inc
15/10/202013:55PR Newswire (Canada)IIROC Trading Halt - COTTSXV:COTCotinga Pharmaceuticals Inc
07/11/201922:10PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - COTTSXV:COTCotinga Pharmaceuticals Inc
07/11/201922:09PR Newswire (Canada)IIROC Trading Resumption - COTTSXV:COTCotinga Pharmaceuticals Inc
24/07/201422:20Marketwired CanadaCritical Outcome Technologies Reports Year-End Financial and Operating ResultsTSXV:COTCotinga Pharmaceuticals Inc
23/06/201415:00MarketwiredCritical Outcome Technologies Seeks to Redefine Personalized Cancer Care With Project ROSALINDTSXV:COTCotinga Pharmaceuticals Inc
17/06/201415:00MarketwiredCritical Outcome Technologies Receives Orphan Drug Designation For COTI-2TSXV:COTCotinga Pharmaceuticals Inc
16/06/201415:00Marketwired CanadaCritical Outcome Technologies to Commence Trading in U.S. on OTCQB Under Symbol COTQFTSXV:COTCotinga Pharmaceuticals Inc
14/06/201401:42Marketwired CanadaCritical Outcome Technologies Inc.: SeeThruEquity Initiates Research CoverageTSXV:COTCotinga Pharmaceuticals Inc
13/06/201415:00MarketwiredCritical Outcome Technologies Invited to Present at 16th International p53 Workshop in SwedenTSXV:COTCotinga Pharmaceuticals Inc
04/06/201415:00MarketwiredCritical Outcome Technologies Inc. Completes FinancingTSXV:COTCotinga Pharmaceuticals Inc
27/05/201422:48Marketwired CanadaCritical Outcome Technologies Inc. Announces Warrant Term AmendmentTSXV:COTCotinga Pharmaceuticals Inc
27/05/201415:00MarketwiredCritical Outcome Technologies Selected to Present at Multiple Investor Conferences in New York CityTSXV:COTCotinga Pharmaceuticals Inc
22/05/201415:00Access WireSeeThruEquity 3rd Annual Microcap Investor Conference To Be Held May 28, 2014TSXV:COTCotinga Pharmaceuticals Inc
01/05/201414:48MarketwiredFinancing Increases Runway to the Clinic for COTI-2, Critical Outcome's Lead Cancer Drug CandidateTSXV:COTCotinga Pharmaceuticals Inc
14/04/201422:30Marketwired CanadaCritical Outcome Technologies Announces Warrant IssuanceTSXV:COTCotinga Pharmaceuticals Inc
04/04/201415:00MarketwiredCritical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian CancerTSXV:COTCotinga Pharmaceuticals Inc
14/03/201414:00MarketwiredCritical Outcome Technologies Reports Third Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
26/02/201415:29MarketwiredCritical Outcome Technologies Identifies Experienced Partner for Clinical Development of COTI-2TSXV:COTCotinga Pharmaceuticals Inc
06/02/201415:13MarketwiredCritical Outcome Technologies Completes Private PlacementTSXV:COTCotinga Pharmaceuticals Inc
05/02/201414:00Marketwired CanadaCritical Outcome Technologies Announces Engagement of Maxim Group LLCTSXV:COTCotinga Pharmaceuticals Inc
18/12/201322:48MarketwiredCritical Outcome Technologies Reports Second Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
06/12/201322:05MarketwiredCritical Outcome Technologies Awards Stock OptionsTSXV:COTCotinga Pharmaceuticals Inc
06/12/201314:47MarketwiredCritical Outcome Technologies Provides Business and Scientific Update at Annual General MeetingTSXV:COTCotinga Pharmaceuticals Inc
13/11/201314:00Marketwired CanadaCOTI-2, a P53 Dependent Treatment for Many Common Cancers, Receives Additional U.S. Patent ProtectionTSXV:COTCotinga Pharmaceuticals Inc
29/10/201321:15Marketwired CanadaCritical Outcome Technologies Announces Warrant Expiry Date AmendmentTSXV:COTCotinga Pharmaceuticals Inc
15/10/201322:30Marketwired CanadaCritical Outcome Technologies Grants Stock OptionsTSXV:COTCotinga Pharmaceuticals Inc
03/10/201315:45Marketwired CanadaCritical Outcome Technologies to Present at the 12th Annual BIO Investor ForumTSXV:COTCotinga Pharmaceuticals Inc
27/09/201322:05Marketwired CanadaCritical Outcome Technologies Reports Fiscal 2014 First Quarter ResultsTSXV:COTCotinga Pharmaceuticals Inc
11/09/201322:05Marketwired CanadaCritical Outcome Technologies Announces Warrant Term AmendmentsTSXV:COTCotinga Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:COT

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
TIT
Telecom Italia
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
CPR
Davide Campari
BIT
AMP
Amplifon
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network